The current NIOSH Pocket Guide sets a 1 mg/m³ time-weighted-average REL for anhydrous sodium borates, describes a white-to-gray odorless powder, and reports eye, skin, and upper-respiratory irritation, dermatitis, nosebleed, cough, and breathing difficulty.
Source: html ↗ · saved source
Exposure Limits; Physical Description; Exposure Routes; Symptoms; Target Organs · 1NIOSH REL TWA 1 mg/m³. Physical Description White to gray, odorless powder. Exposure Routes inhalation, ingestion, skin and/or eye contact. Symptoms irritation eyes, skin, upper respiratory system; dermatitis; epistaxis (nosebleed); cough, dyspnea (breathing difficulty). Target Organs Eyes, skin, respiratory system.
NIOSH lists inhalation, ingestion, skin, and eye contact routes for anhydrous sodium borates and reports eye, skin, and upper-respiratory irritation, dermatitis, nosebleed, cough, and breathing difficulty; target organs are eyes, skin, and respiratory system.
Source: html ↗ · saved source
Symptoms and target organs · 1Exposure Routes: inhalation, ingestion, skin and/or eye contact. Symptoms: irritation eyes, skin, upper respiratory system; dermatitis; epistaxis (nosebleed); cough, dyspnea (breathing difficulty). Target Organs: Eyes, skin, respiratory system.
Source: pdf ↗ · saved source
page 10 · Acute Symptoms · 1Thirty three percent of the workers noted dryness of the mouth, nose, or throat and 28 percent noted eye irritation at exposures of 14.9 mg/m3. Nosebleeds and dry cough were noted by 15 percent, and sore throats and productive cough were noted by 8 percent at this exposure.